The Effect of Gelfoam Impregnated With Botulinum Toxin on Allergic Rhinitis
- PMID: 31384585
- PMCID: PMC6666934
The Effect of Gelfoam Impregnated With Botulinum Toxin on Allergic Rhinitis
Abstract
Introduction: This study evaluated the effect of gelfoam impregnated with botulinum toxin on the symptoms induced by allergic rhinitis.
Materials and methods: In total, 30 patients with allergic rhinitis who did not respond to common therapies were included in this clinical trial study. All patients were treated with intranasal gelfoam impregnated with botulinum toxin type a (40 unit in each side) placed in the middle meatus of each nostril. The main symptoms of allergic rhinitis were scored from zero to three by the patients. Symptoms recorded and compared before and two months after the treatment.
Result: The mean age of patients was 31.03±6.9 years. The mean score for sneezing was 2.23 before the treatment which significantly decreased to 1.06 after the treatment (P<0.05). The mean scores of rhinorrhea, nasal congestion, and nasal itching were 2.53, 2.03, and 1.93, respectively, before the treatment which significantly decreased to 0.93, 1, and 0.8 after the treatment (P<0.05). No reported side effects was observed in this study.
Conclusion: According to the results, treatment with gelfoam impregnated with botulinum toxin is an effective and safe method in patients who have not responded to common therapies for allergic rhinitis. Accordingly, it is recommended to relieve symptoms in patients with seasonal allergic rhinitis in order to maintain the effectiveness of this treatment at least 8 weeks.
Keywords: Allergic rhinitis; Botulinum toxin; Gelfoam.
Similar articles
-
Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.Clin Exp Allergy. 2004 Feb;34(2):259-67. doi: 10.1111/j.1365-2222.2004.01877.x. Clin Exp Allergy. 2004. PMID: 14987306 Clinical Trial.
-
Botulinum Toxin for Rhinitis.Curr Allergy Asthma Rep. 2016 Aug;16(8):58. doi: 10.1007/s11882-016-0636-3. Curr Allergy Asthma Rep. 2016. PMID: 27461136 Review.
-
Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial.Acta Otolaryngol. 2003 Dec;123(9):1060-3. doi: 10.1080/00016480310000755. Acta Otolaryngol. 2003. PMID: 14710908 Clinical Trial.
-
Comparing The Effects of Botulinum toxin-A and multiple surgical parasympathectomy on treatment of allergic rhinitis.Am J Otolaryngol. 2023 Jul-Aug;44(4):103893. doi: 10.1016/j.amjoto.2023.103893. Epub 2023 Apr 10. Am J Otolaryngol. 2023. PMID: 37060783
-
Turbinate Injection of Botulinum Toxin in the Treatment of the Chronic Rhinitis.Laryngoscope. 2025 May;135(5):1545-1552. doi: 10.1002/lary.31936. Epub 2024 Dec 3. Laryngoscope. 2025. PMID: 39625109
Cited by
-
[Research progress of botulinum toxin type A in the treatment of chronic rhinitis].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Nov;36(11):878-883. doi: 10.13201/j.issn.2096-7993.2022.11.015. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022. PMID: 36347585 Free PMC article. Review. Chinese.
-
Temperature-controlled radiofrequency neurolysis for treatment of chronic rhinitis: 12-month outcomes after treatment in a randomized controlled trial.Int Forum Allergy Rhinol. 2023 Feb;13(2):107-115. doi: 10.1002/alr.23047. Epub 2022 Jul 5. Int Forum Allergy Rhinol. 2023. PMID: 35714267 Free PMC article. Clinical Trial.
-
Effect of Radiofrequency Neurolysis on the Symptoms of Chronic Rhinitis: A Randomized Controlled Trial.OTO Open. 2021 Sep 10;5(3):2473974X211041124. doi: 10.1177/2473974X211041124. eCollection 2021 Jul-Sep. OTO Open. 2021. PMID: 34527852 Free PMC article.
-
Long-term Outcomes Following Temperature-Controlled Radiofrequency Neurolysis for the Treatment of Chronic Rhinitis.Allergy Rhinol (Providence). 2022 May 29;13:21526575221096045. doi: 10.1177/21526575221096045. eCollection 2022 Jan-Dec. Allergy Rhinol (Providence). 2022. PMID: 35663498 Free PMC article.
-
A Novel Technique for the Topical Application of Botulinum Neurotoxin A to the Nasal Mucosa in Reducing Rhinitis Symptoms.Cureus. 2024 Dec 9;16(12):e75426. doi: 10.7759/cureus.75426. eCollection 2024 Dec. Cureus. 2024. PMID: 39791060 Free PMC article.
References
-
- Bauchau V, Durham S. Prevalence and rate of diagnosis of allergic rhinitis in Europe. European Respiratory Journal. 2004;24(5):758–64. - PubMed
-
- Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care. 2000;6(3):373–8. - PubMed
-
- Okubo K, Kurono Y, Fujieda S, Ogino S, Uchio E, Odajima H, et al. Japanese guideline for allergic rhinitis. Allergology International. 2011;60(2):171–89. - PubMed
-
- Sardana N, Craig TJ. Congestion and sleep impairment in allergic rhinitis. Asian Pacific journal of allergy and immunology. 2011;29(4):297. - PubMed
LinkOut - more resources
Full Text Sources